Harvey K Chong, PA
Physician Assistant · Sunnyvale
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
On the public record
- 1 Medical Board action on record
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Harvey K Chong’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C52730 · Cancelled
Licence status: Cancelled · since 2007 · University of Ghana Medical School.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 1990-05-03 | Board disciplineDiscipline | Revoked. · 10 1990001714 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$28,100
Medicare paid this office $28,100 for 115 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 26 | $8,858 | None |
| Aspiration and/or injection of fluid from large joint | 56 | $7,041 | $59 |
| Return visit (30+ min) | 23 | $1,999 | $83 |
| Short return visit (20+ min) | 20 | $1,696 | $71 |
| Short return visit | 23 | $1,146 | $46 |
See all 7 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 26 | $8,858 | None |
| Aspiration and/or injection of fluid from large joint | 56 | $7,041 | $59 |
| Return visit (30+ min) | 23 | $1,999 | $83 |
| Short return visit (20+ min) | 20 | $1,696 | $71 |
| Short return visit | 23 | $1,146 | $46 |
| New patient visit (30+ min) | 12 | $1,098 | $92 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $117 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 32 | More than 76% of doctors who do this |
Who their Medicare patients are
115 Original Medicare patients in 2024. Average age 74 · Women 70% · Also on Medicaid 12% · Health risk score 0.78. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 62% · Coronary heart disease 21% · Diabetes 20% · Chronic kidney disease 15% · Cancer 13% · Depression 12% · COPD 10%.
The office billed $145,846, Medicare allowed $37,149 and paid $28,100; for 585 services of 29 kinds; $10,367 of it was for drugs given in the office and $17,733 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 115 | 585 | 74 | 0.78 | $145,846 | $28,100 |
| 2023 | 123 | 956 | 74 | 0.82 | $169,377 | $29,107 |
| 2022 | 116 | 409 | 74 | 0.71 | $136,149 | $28,731 |
| 2021 | 98 | 380 | 74 | 0.92 | $113,639 | $22,719 |
| 2020 | 61 | 207 | 75 | 0.94 | $78,539 | $14,227 |
| 2019 | 76 | 209 | 72 | 1.06 | $90,236 | $19,974 |
| 2018 | 81 | 121 | 64 | 1.47 | $52,815 | $7,853 |
| 2017 | 192 | 248 | 62 | 1.71 | $93,404 | $12,812 |
| 2016 | 155 | 193 | 63 | 1.82 | $67,684 | $10,578 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 23 | $7,591 | None |
| Aspiration and/or injection of fluid from large joint | 51 | $5,360 | $62 |
| Short return visit (20+ min) | 38 | $2,874 | $67 |
| Return visit (30+ min) | 25 | $2,660 | $106 |
| Repair of shoulder rotator cuff using an endoscope | 19 | $2,622 | $138 |
| Prosthetic repair of shoulder joint, total shoulder | 13 | $2,390 | $184 |
| Short return visit | 23 | $1,284 | $43 |
| New patient visit (30+ min) | 14 | $1,154 | $82 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 16 | $337 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $103 | None |
2022: 10 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 34 | $10,352 | None |
| Aspiration and/or injection of fluid from large joint | 48 | $5,181 | $60 |
| Short return visit (20+ min) | 35 | $2,944 | $72 |
| Prosthetic repair of shoulder joint, total shoulder | 15 | $2,747 | $183 |
| Repair of shoulder rotator cuff using an endoscope | 14 | $1,928 | $138 |
| Return visit (30+ min) | 15 | $1,472 | $92 |
| New patient visit (30+ min) | 14 | $1,137 | $81 |
| Short return visit | 12 | $616 | $44 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 14 | $297 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $71 | None |
2021: 7 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 19 | $7,033 | None |
| Aspiration and/or injection of fluid from large joint | 43 | $5,217 | $61 |
| Short return visit (20+ min) | 28 | $2,908 | $77 |
| Repair of shoulder rotator cuff using an endoscope | 13 | $1,810 | $139 |
| New patient visit (30+ min) | 18 | $1,372 | $76 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 13 | $281 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $85 | None |
2020: 5 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 18 | $5,116 | None |
| Aspiration and/or injection of fluid from large joint | 24 | $2,663 | $59 |
| Repair of shoulder rotator cuff using an endoscope | 15 | $2,078 | $139 |
| Short return visit (20+ min) | 21 | $1,291 | $54 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $262 | $22 |
2019: 7 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 11 | $8,604 | None |
| Repair of shoulder rotator cuff using an endoscope | 21 | $2,604 | $124 |
| Prosthetic repair of shoulder joint, total shoulder | 12 | $2,183 | $182 |
| Aspiration and/or injection of fluid from large joint | 19 | $2,128 | $58 |
| Short return visit (20+ min) | 13 | $852 | $57 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 23 | $479 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $31 | None |
2018: 3 services
| Repair of shoulder rotator cuff using an endoscope | 12 | $1,587 | $132 |
| Emergency department visit with low level of medical decision making | 32 | $1,391 | $43 |
| Emergency department visit with moderate level of medical decision making | 11 | $973 | $88 |
2017: 4 services
| Emergency department visit with moderate level of medical decision making | 76 | $5,069 | $67 |
| Emergency department visit with high level of medical decision making | 35 | $3,336 | $95 |
| Emergency department visit with low level of medical decision making | 78 | $2,887 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $76 | $5 |
2016: 3 services
| Emergency department visit with moderate level of medical decision making | 43 | $3,282 | $76 |
| Emergency department visit with low level of medical decision making | 79 | $3,112 | $39 |
| Emergency department visit with high level of medical decision making | 26 | $3,003 | $115 |
Drugs they prescribed that Part D paid
$522
Pharmacies billed $522 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 55% of their Part D prescriptions (28 of 51) in 2024. A higher opioid share than 9 in 10 peers; the typical physician assistant clinician is at 1%.
51 generic and 0 brand-name prescriptions · $522 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 13 | $164 | $12 |
Year by year
| 2024 | 51 | 34 | 55% (28) | 0% | $522 |
| 2023 | 76 | 41 | 45% (34) | 0% | $1,028 |
| 2022 | 38 | 24 | 58% (22) | None | $760 |
| 2021 | 61 | 31 | 46% (28) | 0% | $421 |
| 2020 | 37 | 27 | 54% (20) | 0% | $217 |
| 2019 | 37 | 31 | 54% (20) | None | $376 |
| 2018 | 53 | 31 | None | None | $474 |
| 2017 | 171 | 100 | 12% (20) | None | $2,482 |
| 2016 | 94 | 66 | None | 14% | $1,967 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Hydrocodone-Acetaminophen | 22 | $240 | $11 |
| Meloxicam | 14 | $85 | $6 |
2021: 2 drugs
| Hydrocodone-Acetaminophen | 14 | $135 | $10 |
| Meloxicam | 11 | $90 | $8 |
2020: 1 drug
| Hydrocodone-Acetaminophen | 14 | $102 | $7 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 18 | $131 | $7 |
2017: 5 drugs
| Cephalexin | 15 | $113 | $8 |
| Sulfamethoxazole-Trimethoprim | 18 | $95 | $5 |
| Hydrocodone-Acetaminophen | 17 | $64 | $4 |
| Ibuprofen | 12 | $48 | $4 |
| Ondansetron Odt | 13 | $46 | $4 |
2016: 1 drug
| Ibuprofen | 15 | $64 | $4 |
Money from drug and device companies
$194 in 2025
| 2025 | 3 | 3 | None | $194 |
| 2024 | 2 | 2 | None | $300 |
| 2023 | 1 | 1 | None | $30 |
| 2022 | 1 | 1 | None | $25 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medical Device Business Services | Ethicon | $149 | 1 payment
|
| Bioventus | Durolane | $27 | 1 payment
|
| Ferring Pharmaceuticals | Euflexxa | $18 | 1 payment
|
See all 3 published payments
| Ferring Pharmaceuticals | Meals · 2025-08-07 | Euflexxa | $18 |
| Medical Device Business Services | Meals · 2025-06-13 | Ethicon | $149 |
| Bioventus | Meals · 2025-04-28 | Durolane | $27 |
See earlier years (2024, 2023, 2022)
2024: $300
| Bioventus | Durolane | $150 | 1 payment
|
| Medical Device Business Services | Ethicon | $150 | 1 payment
|
2023: $30
| Ferring Pharmaceuticals | Euflexxa | $30 | 1 payment
|
2022: $25
| Pacira Pharmaceuticals | Iovera | $25 | 1 payment
|
Professional record
- NPI
- 1982070744
- Licence
- CA 52730California C52730: Cancelled
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2015-08-17
- NPI last updated
- 2020-02-15
- NPI record certified
- 2020-02-15
This is when the NPI record was last certified, not a medical board exam.